Status:

TERMINATED

A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein IV Catheter In a Pediatric Population

Lead Sponsor:

Optomeditech Oy

Collaborating Sponsors:

Hospital District of Helsinki and Uusimaa

CardioMed Device Consultants, LLC

Conditions:

Peripheral Venous Catheterization

Eligibility:

All Genders

Up to 12 years

Phase:

NA

Brief Summary

A prospective, single-center, open-label, randomized controlled trial to demonstrate the safety and efficacy of the OptiVein IV Catheter in the pediatric population. The study hypothesis is that OptiV...

Detailed Description

The OptiVein System uses transillumination of skin tissue to aid in cannulation and consists of the OptiVein IV Catheter with an integrated optical fiber, and an electronic unit. The electronic unit i...

Eligibility Criteria

Inclusion

  • Aged newborn to 12 years
  • Has written or verbal order for insertion of an IV
  • Requires peripheral IV therapy (catheter)
  • Has an insertion site in the hand, forearm, foot, leg, or head free of deformities, phlebitis, infiltration, dermatitis, burns, lesions or tattoos
  • Demonstrates cooperation with a catheter insertion and the study protocol

Exclusion

  • In the newborn nursery or intensive care units (neonatal or pediatric)
  • On patient-controlled analgesia pump
  • Patient is anesthetized
  • Terminally ill
  • Transferred from the operating room less than 8 hours postanasthesia
  • Any child the research staff deem unobservable
  • The study IV catheter site will be placed below an old infusion site
  • The study IV site needs to be immobilized with a splint or other devices
  • Has or has had a previous IV catheter related phlebitis or infiltration during current hospitalization
  • Will require a power injection for a radiologic procedure during participation in this study

Key Trial Info

Start Date :

October 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 25 2016

Estimated Enrollment :

188 Patients enrolled

Trial Details

Trial ID

NCT02265380

Start Date

October 1 2014

End Date

August 25 2016

Last Update

March 1 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Helsinki and Uusimaa Hospital District, Children's Hospital

Helsinki, Finland, 00029